… in patients who received cell infusion. However, we noted an unexpectedly high rate of in-stent
restenosis at culprit lesion in … -up in the cell infusion group we noted improvements in left …

… pertinent to the design of clinical trials in the field of AF ablation, … care professionals who are
involved in the care of patients with … in light of all the circumstances presented by that patient. …

… in the specific examples discussed in detail in this review. A schematic phase diagram can
be drawn as in Figure 1 in … is schematic, in part because the problem is unsolved and in part …

… in the intestinal homeostasis results in the defective mucus barrier with increased permeability
that results in … This review briefly summarizes the recent progress made in understanding …

… We identified all patients and health-care workers who had been in the emergency room …
exposure in the emergency room: in the same zone as the index case (group A), in different …

… in the MAGIC consortium. This result might be because of the low allele frequency of the T
allele in Europeans (0.20 in the MAGIC consortium and 0.38 in this … in the MAGIC consortium). …

… , the CNPs used in this study progressively accumulated in the tumor tissues by the EPR
effect within 24 h and lasted up to 10 days with considerably low uptake in the liver and spleen. …

… were 400 nm in diameter and were stable in PBS for 10 days… loaded dose was released in
8 days at 37 C in PBS). Owing to … than free paclitaxel formulated in Cremophor EL. Injection of …

In this study, we propose a new bioactive bone cement (BBC), … in vitro. Scanning electron
microscopy (SEM) and radiological and histological examinations were performed in animal …

… in 14 patients (7.2%) in the treatment group and in 27 patients (13.4%) in the placebo group
(hazard ratio in the … in 48.4% of the patients in the treatment group and in 15.0% of those …